Latest Commercialization News

Vection Technologies reports a record quarter-to-date cash intake of approximately $14 million and a robust $50 million forward pipeline, underscoring strong momentum across defence, AI, healthcare, and retail sectors.

Echo IQ has formally lodged its FDA 510(k) submission for EchoSolv HF, an AI-driven heart failure diagnostic software validated by Mayo Clinic data, aiming to tap into a $60 billion US market.

New Frontier Minerals is wrapping up its first reverse circulation drilling at Harts Range, with samples now en route for assay analysis. Meanwhile, progress at the Big One Deposit mining lease signals advancing copper ambitions.

Elevate Uranium has successfully assembled its U-pgrade™ Demonstration/Pilot Plant in Namibia, with steady state operations expected to start in January 2026. This milestone aims to validate a proprietary beneficiation process that could transform uranium processing economics.

Korab Resources reports significant gold and base metals exploration progress at its Rum Jungle Project, alongside innovative mining method evaluations and ongoing legal challenges to key lease renewals.

Robex Resources has reached a pivotal milestone at its Kiniéro Gold Project in Guinea by delivering first ore to the mill, setting the stage for first gold production expected this month.

Janus Electric reports strong progress in truck conversions and US export orders while navigating a delay in expected EVUNI investment funding, secured by interim asset-backed financing.

Charter Hall Long WALE REIT has announced an ordinary unfranked quarterly distribution of AUD 0.06375 per security, payable in February 2026, alongside a Dividend Reinvestment Plan offering a 1% discount.

Medallion Metals has completed a Feasibility Study for its Ravensthorpe Gold Project, confirming robust economics and a clear pathway to near-term gold and copper production leveraging existing infrastructure in Western Australia.

An independent meta-analysis presented at the ASH Annual Meeting reveals Mesoblast’s remestemcel-L achieves superior remission rates and safety outcomes compared to ruxolitinib in treating steroid-refractory acute graft-versus-host disease.

ABx Group has secured a new five-year exploration licence in northern Tasmania, expanding its rare earths tenure between key deposits and advancing its high-value rare earth product development.

Metallium Limited has resumed trading on the ASX following news of a significant collaboration and funding deal with a US partner to advance its critical-metals recovery technology.